Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Albuminuria as a marker of systemic congestion in patients with heart failure( )
Boorsma, E. M., Ter Maaten, J. M., Damman, K., van Essen, B. J., Zannad, F., van Veldhuisen, D. J., Samani, N. J., Dickstein, K., Metra, M., Filippatos, G., Lang, C. C., Ng, L., Anker, S. D., Cleland, J. G., Pellicori, P., Gansevoort, R. T., Heerspink, H. J. L., Voors, A. A. & Emmens, J. E., 1-Feb-2023, In: European Heart Journal. 44, 5, p. 368-380 13 p., ehac528.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile7 Citations (Scopus)14 Downloads (Pure) -
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Schnell, O., Battelino, T., Bergenstal, R., Birkenfeld, A. L., Ceriello, A., Cheng, A., Davies, M., Edelman, S., Forst, T., Giorgino, F., Green, J., Groop, P. H., Hadjadj, S., J.L.Heerspink, H., Hompesch, M., Izthak, B., Ji, L., Kanumilli, N., Mankovsky, B., Mathieu, C., & 16 others, 2023, In: Cardiovascular Diabetology. 22, 1, 12 p., 59.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)
Green, J. B., Mottl, A. K., Bakris, G., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Nangaku, M., Rossing, P., Scott, C., Gay, A. & Agarwal, R., Apr-2023, In: Nephrology Dialysis Transplantation. 38, 4, 10 p., gfac198.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile24 Citations (Scopus)150 Downloads (Pure) -
Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease
Gregorich, M., Kammer, M., Heinzel, A., Böger, C., Eckardt, K. U., Heerspink, H. L., Jung, B., Mayer, G., Meiselbach, H., Schmid, M., Schultheiss, U. T., Heinze, G. & Oberbauer, R., 5-Apr-2023, In: Jama network open. 6, 4, 13 p., E231870.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)10 Downloads (Pure) -
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Craig, J. C., Tunnicliffe, D. J., Tonelli, M., Cheung, M., Earley, A., Rossing, P., & 2 others, 1-Mar-2023, In: Annals of Internal Medicine. 176, 3, p. 381-387 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Citations (Scopus)
Activities
-
Asian-Australian Diabetes Meeting
Hiddo Lambers Heerspink (Invited speaker)
24-Aug-2019Activity: Talk and presentation › Academic presentation › Academic
-
Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas
Jasper Stevens (Speaker) & Hiddo Heerspink (Speaker)
29-Jan-2019Activity: Talk and presentation › Professional or public presentation › Professional
-
European Association for the Study of Diabetes (EASD) Barcelona 2019
Hiddo Lambers Heerspink (Invited speaker)
17-Sept-2019Activity: Talk and presentation › Academic presentation › Academic
-
ASN Kidney week
Hiddo Lambers Heerspink (Speaker)
7-Nov-2019 → 9-Nov-2019Activity: Talk and presentation › Academic presentation › Academic
-
Antihyperglycemic agents and albuminuria
Hiddo Lambers Heerspink (Speaker)
Jun-2018Activity: Talk and presentation › Professional or public presentation › Professional
Datasets
-
Dataset for: Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease
Tighiouart, H. (Contributor), Vonesh, E. (Contributor), Lambers Heerspink, H. (Contributor), Staplin, N. (Contributor), Lewis, J. (Contributor), Inker, L. (Contributor), Ying, J. (Contributor) & Greene, T. (Contributor), University of Groningen, 31-Jul-2019
DOI: 10.6084/m9.figshare.8214638.v1
Dataset
-
Supplementary Material for: Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Chin, M. P. (Contributor), Bakris, G. L. (Contributor), Block, G. A. (Contributor), Chertow, G. M. (Contributor), Goldsberry, A. (Contributor), Inker, L. A. (Contributor), Lambers Heerspink, H. (Contributor), O'Grady, M. (Contributor), Pergola, P. E. (Contributor), Wanner, C. (Contributor), Warnock, D. G. (Contributor) & Meyer, C. J. (Contributor), University of Groningen, 18-Jan-2018
DOI: 10.6084/m9.figshare.5798001.v1
Dataset
-
Supplementary Material for: A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) – Study Design and Baseline Characteristics
Eder, S. (Contributor), Leierer, J. (Contributor), Kerschbaum, J. (Contributor), Rosivall, L. (Contributor), Wiecek, A. (Contributor), de Zeeuw, D. (Contributor), Mark, P. B. (Contributor), Heinze, G. (Contributor), Rossing, P. (Contributor), Lambers Heerspink, H. (Contributor) & Mayer, G. (Contributor), University of Groningen, 21-Feb-2018
DOI: 10.6084/m9.figshare.5909164.v1
Dataset
-
Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Lienczewski, C. (Contributor), Karihaloo, A. (Contributor), Kretzler, M. (Contributor), Dutius Andersson, A. (Contributor), Pontrelli, P. (Contributor), Gesualdo, L. (Contributor), Sharma, K. (Contributor), Welberry Smith, M. (Contributor), Gooding, K. M. (Contributor), Shore, A. C. (Contributor), Ibberson, M. (Contributor), Lambers Heerspink, H. (Contributor), Gomez, M. F. (Contributor), Gilchrist, M. (Contributor), Nuutila, P. (Contributor), Teh, I. (Contributor), Mansfield, M. (Contributor), Papale, M. (Contributor), Banks, R. E. (Contributor), Bailey, J. (Contributor), Andress, D. (Contributor), Koivuviita, N. (Contributor), Sourbron, S. (Contributor), Tobin, K. (Contributor), Metsärinne, K. (Contributor), Zetterqvist, A. (Contributor), Garcia Hernandez, A. (Contributor), de Zeeuw, D. (Contributor), Ball, C. (Contributor), Grenier, N. (Contributor), Saunavaara, V. (Contributor), Maziarz, M. (Contributor), Gilmour, P. S. (Contributor), Shelley, D. (Contributor) & Puppala, S. (Contributor), University of Groningen, 29-Jun-2020
DOI: 10.6084/m9.figshare.12586625.v1
Dataset
-
Supplementary Material for: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Levin, A. (Contributor), Greene, T. (Contributor), de Zeeuw, D. (Contributor), Edwards, R. (Contributor), Pollock, C. (Contributor), Zhang, H. (Contributor), Lambers Heerspink, H. (Contributor), Bakris, G. L. (Contributor), Desai, M. (Contributor), Agarwal, R. (Contributor), Neal, B. (Contributor), Jardine, M. J. (Contributor), Zinman, B. (Contributor), Cannon, C. P. (Contributor), Perkovic, V. (Contributor), Bull, S. (Contributor), Brenner, B. M. (Contributor), Mahaffey, K. W. (Contributor), Wheeler, D. C. (Contributor), Charytan, D. M. (Contributor) & Xie, J. (Contributor), University of Groningen, 13-Dec-2017
DOI: 10.6084/m9.figshare.5696959.v1, https://doi.org/10.6084%2Fm9.figshare.5696959.v1
Dataset
Press/Media
-
A Study to Assess the Effects of Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
05/10/2022
1 item of Media coverage
Press/Media: Research › Popular
-
Diabetes drug can slow kidney function decline, study finds
05/07/2022
1 item of Media coverage
Press/Media: Research › Academic
-
La dapagliflozina no reduce los riesgos en los pacientes hospitalizados con COVID-19
29/04/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Does the Drug Dapagliflozin Benefit Hospitalized Patients with Covid-19?
29/04/2022
2 Media contributions
Press/Media: Expert Comment › Professional
-
SGLT2 Inhibitor Safe for Kidneys in Hospitalized COVID Patients
29/04/2022
1 Media contribution
Press/Media: Expert Comment › Professional